Physician profile
Austin Loranger
NPI 1952857591
$1,204.82
in general payments reported to CMS, 2019-2025
17 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.34 · 2022: $308 · 2023: $491 · 2024: $220 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627 · Education: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.72 |
| Education | $257.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $248.41 | 2022-2024 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $204.41 | 2021-2025 | Fasenra, Breztri, Tagrisso |
| United Therapeutics Corporation | $112.42 | 2022-2024 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.70 | 2023-2025 | Ofev |
| Exthera Medical Corporation | $73.57 | 2022 | |
| Sanofi-Aventis U.S. LLC | $70.99 | 2023 | |
| Genzyme Corporation | $61.38 | 2022-2023 | |
| Glaxosmithkline, LLC. | $51.14 | 2022-2025 | Nucala |
| Actelion Pharmaceuticals US, INC. | $40.97 | 2022-2023 | Opsumit, Uptravi |
| Abiomed | $39.00 | 2023 | Impella |
| Philips North America LLC | $35.64 | 2022-2024 | (Ak6) Vest Therapy |
| Baxter Healthcare | $35.26 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $33.59 | 2022-2023 | Glassia |
| Insmed, INC. | $27.41 | 2025 | Arikayce |
| Merck Sharp & Dohme LLC | $25.01 | 2024 | Winrevair |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.52 | 2022 | |
| Amgen INC. | $15.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Loranger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.